156 related articles for article (PubMed ID: 19819883)
1. Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?
Immenschuh S
Cardiovasc Res; 2009 Dec; 84(3):341-2. PubMed ID: 19819883
[No Abstract] [Full Text] [Related]
2. [Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Lotersztajn S; Teixeira-Clerc F; Hezode C; Tran van Nhieu J; Deveaux V; Mallat A
Gastroenterol Clin Biol; 2007 Mar; 31(3):255-8. PubMed ID: 17396081
[No Abstract] [Full Text] [Related]
3. Attenuation of allergic contact dermatitis through the endocannabinoid system.
Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A
Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587
[TBL] [Abstract][Full Text] [Related]
4. [The endocannabinoid system].
Sudano I; Périat D; Noll G
Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
7. Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk.
Mach F; Montecucco F; Steffens S
Pharmacol Rep; 2009; 61(1):13-21. PubMed ID: 19307689
[TBL] [Abstract][Full Text] [Related]
8. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
9. End of the line for cannabinoid receptor 1 as an anti-obesity target?
Jones D
Nat Rev Drug Discov; 2008 Dec; 7(12):961-2. PubMed ID: 19043439
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors.
Samaha FF; Chou CM
Obesity (Silver Spring); 2009 Feb; 17(2):220-5. PubMed ID: 19039319
[No Abstract] [Full Text] [Related]
11. [Blocking the endocannabinoid system -- weight reduction and cardiovascular risk management].
Bramlage P; Böcking W; Kirch W
Dtsch Med Wochenschr; 2005 Mar; 130(12):665-8. PubMed ID: 15776349
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity.
Leite CE; Mocelin CA; Petersen GO; Leal MB; Thiesen FV
Pharmacol Rep; 2009; 61(2):217-24. PubMed ID: 19443932
[TBL] [Abstract][Full Text] [Related]
13. [Endocannabinoid system and bowel inflammation].
Márquez L; Abanades S; Andreu M
Med Clin (Barc); 2008 Oct; 131(13):513-7. PubMed ID: 19007582
[TBL] [Abstract][Full Text] [Related]
14. Retrograde signalling by endocannabinoids.
Vaughan CW; Christie MJ
Handb Exp Pharmacol; 2005; (168):367-83. PubMed ID: 16596781
[TBL] [Abstract][Full Text] [Related]
15. [Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system].
Ducobu J; Sternon J
J Pharm Belg; 2005; 60(3):89-91. PubMed ID: 16252510
[TBL] [Abstract][Full Text] [Related]
16. The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
Meletis C
Altern Ther Health Med; 2019 Jun; 25(S2):24-28. PubMed ID: 31202201
[TBL] [Abstract][Full Text] [Related]
17. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages.
Sugamura K; Sugiyama S; Nozaki T; Matsuzawa Y; Izumiya Y; Miyata K; Nakayama M; Kaikita K; Obata T; Takeya M; Ogawa H
Circulation; 2009 Jan; 119(1):28-36. PubMed ID: 19103987
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacology of cannabinoid receptors].
Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid system and fear conditioning.
Resstel LB; Moreira FA; Guimarães FS
Vitam Horm; 2009; 81():421-40. PubMed ID: 19647121
[TBL] [Abstract][Full Text] [Related]
20. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
